HLHIX
Price
$29.59
Change
-$0.17 (-0.57%)
Updated
Feb 21 closing price
Net Assets
119.6M
JNGLX
Price
$71.57
Change
-$0.51 (-0.71%)
Updated
Feb 21 closing price
Net Assets
5B
Ad is loading...

HLHIX vs JNGLX

Header iconHLHIX vs JNGLX Comparison
Open Charts HLHIX vs JNGLXBanner chart's image
Virtus KAR Health Sciences Inst
Price$29.59
Change-$0.17 (-0.57%)
VolumeN/A
Net Assets119.6M
Janus Henderson Global Life Sciences D
Price$71.57
Change-$0.51 (-0.71%)
VolumeN/A
Net Assets5B
HLHIX vs JNGLX Comparison Chart
Loading...
View a ticker or compare two or three
VS
HLHIX vs. JNGLX commentary
Feb 23, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is HLHIX is a Buy and JNGLX is a Buy.

Ad is loading...
FUNDAMENTALS
Fundamentals
JNGLX has more cash in the bank: 5B vs. HLHIX (120M). JNGLX pays higher dividends than HLHIX: JNGLX (0.12) vs HLHIX (0.00). HLHIX was incepted earlier than JNGLX: HLHIX (10 years) vs JNGLX (26 years). HLHIX is a more actively managed with annual turnover of: 75.00 vs. JNGLX (34.00). JNGLX has a lower initial minimum investment than HLHIX: JNGLX (2500) vs HLHIX (1000000). JNGLX annual gain was more profitable for investors over the last year : -3.67 vs. HLHIX (-6.33). JNGLX return over 5 years is better than : 17.54 vs. HLHIX (-15.64).
HLHIXJNGLXHLHIX / JNGLX
Total Expense RatioN/AN/A-
Annual Report Gross Expense RatioN/AN/A-
Fund Existence10 years26 years-
Gain YTD3.1015.42157%
Front LoadN/AN/A-
Min. Initial Investment1000000250040,000%
Min. Initial Investment IRAN/AN/A-
Net Assets120M5B2%
Annual Yield % from dividends0.000.12-
Returns for 1 year-6.33-3.67173%
Returns for 3 years-5.5815.97-35%
Returns for 5 years-15.6417.54-89%
Returns for 10 years-15.9829.25-55%
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
MGRAX44.46-0.12
-0.27%
MFS International Growth A
DBOCX23.75-0.30
-1.25%
BNY Mellon Balanced Opportunity C
PMPRX15.37-0.29
-1.85%
Principal MidCap Value I R3
TETAX13.61-0.29
-2.09%
RBC Enterprise A
GSXPX54.04-1.36
-2.45%
Goldman Sachs Small Cp Val Insghts P